# GLP-1 - Regulatory Mechanism of Postprandial Glycemia

> **NCT00980083** · PHASE1 · COMPLETED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 12 (actual)

## Conditions studied

- Healthy Subjects
- Gastric Emptying

## Interventions

- **DRUG:** Saline
- **DRUG:** Exendin(9-39)amide

## Key facts

- **NCT ID:** NCT00980083
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2005-07
- **Final completion:** 2007-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2009-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980083, "GLP-1 - Regulatory Mechanism of Postprandial Glycemia". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00980083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*